Atom | Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices

Due Dates: September 16, 2025 (Stage 1) | April 16, 2026 (Stage 2)

Funding Amounts: €6–8 million per project (lump sum); total call budget €40 million; up to 5 projects funded

Summary: Funds multinational clinical studies to generate robust evidence for orphan and breakthrough medical devices, advancing innovation and competitiveness in the EU health industry.

Key Information: Two-stage application; minimum two EU/Associated Countries; strong emphasis on regulatory strategy and stakeholder engagement.

Facilitating the conduct of multinational clinical studies of orphan devices and/or of highly innovative (“breakthrough”) devices - European Commission

Sign in to see full grant listing